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Abstract
The Two-Component System (TCS) AbrA1/A2 from Streptomyces coelicolor M145 is a negative regulator of antibiotic
production and morphological differentiation. In this work we show that it is able to auto-regulate its expression, exerting a
positive induction of its own operon promoter, and that its activation is dependent on the presence of iron. The
overexpression of the abrA2 response regulator (RR) gene in the mutant DabrA1/A2 results in a toxic phenotype. The reason
is an excess of phosphorylated AbrA2, as shown by phosphoablative and phosphomimetic AbrA2 mutants. Therefore, non-
cognate histidine kinases (HKs) or small phospho-donors may be responsible for AbrA2 phosphorylation in vivo. The results
suggest that in the parent strain S. coelicolor M145 the correct amount of phosphorylated AbrA2 is adjusted through the
phosphorylation-dephosphorylation activity rate of the HK AbrA1. Furthermore, the ABC transporter system, which is part of
the four-gene operon comprising AbrA1/A2, is necessary to de-repress antibiotic production in the TCS null mutant. Finally,
in order to test the possible biotechnological applications of the DabrA1/A2 strain, we demonstrate that the production of
the antitumoral antibiotic oviedomycin is duplicated in this strain as compared with the production obtained in the wild
type, showing that this strain is a good host for heterologous antibiotic production. Thus, this genetically modified strain
could be interesting for the biotechnology industry.
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Introduction
The regulatory systems involved in secondary metabolite
production in Streptomyces are key targets for metabolic engineer-
ing possibilities [1]. The signals detected by pleiotropic regulators,
which control both morphological differentiation and antibiotic
production in this genus, are ultimately transmitted to the
pathway-specific regulators that eventually switch on/off the
transcription of the biosynthesis-related genes. A close relationship
between the morphogenetic program and antibiotic production
has been described in this genus [2]. TCSs are widespread
signaling regulators that mediate cascades with pleiotropic effects.
The existence of many TCSs in Streptomyces correlates with many
alternative pathways to respond to all types of physiological
situations and environmental changes [3].
In all canonical TCSs, there must be a signal sensed by the
histidine kinase (HK), which then becomes auto-phosphorylated in
the histidine residue. It is not easy to determine the signal that a
specific TCS responds to. To date only a few TCS-activating
signals have been described in Streptomyces and hence under-
standing the control of the regulatory networks remains a
challenge [3,4].
Phosphorylated HK has the ability to phosphotransfer phos-
phate to an aspartic residue of the response regulator (RR),
eliciting a conformational change and its activation. Many studies
addressing the partner fidelity of this process have been conducted.
In theory, the kinetics are more favorable between partners,
although in some cases it is possible that an HK might
phosphorylate different RRs [5]. In fact, a bioinformatic tool has
been developed to predict inter-species crosstalk [6]. The
phosphorylation of the RRs may also take place in the absence
of its cognate HK by small phospho-donors such as acetylpho-
sphate, carbamoylphosphate and phosphoramidate [7,8]. The
half-life of the phosphorylated RRs may vary from seconds to
hours, and dephosphorylation is carried out by phosphatases.
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Sometimes, external proteins carry out this reaction, yet in many
cases the cognate HK is responsible and it also exhibits
phosphatase activity against the corresponding RR. In any case,
the phosphorylation state of the RR is crucial for its activity and
must be strictly regulated. The amount of RR in the cells is also
controlled at transcriptional level. Remarkably, a positive feedback
is often found in the expression of the RR, where the active form
of the regulator activates its own expression [9].
In Streptomyces coelicolor M145, AbrA1/A2 TCS acts as a
pleiotropic negative regulator of antibiotic production and
differentiation [10]. The absence of both genes, abrA1 and abrA2,
enhances actinorhodin (ACT), undecylprodiginine (RED) and
calcium-dependent antibiotic (CDA) production, and it also
accelerates the developmental program. The abrA1 and abrA2
genes of this TCS are part of a four-gene operon harboring
another two upstream genes encoding an ABC transport protein
system (SCOs1742/1743).
In this work we further characterize the AbrA TCS. First, we
were interested in exploring which signal was able to trigger the
AbrA pathway by activating the HK AbrA1 and we observed that
this system depends on Fe. Second, we demonstrate that AbrA
system exerts a positive auto-regulation and that a basal expression
of the adjacent ABC system is necessary for the de-repression
observed in the mutant lacking the TCS genes of the operon.
Additionally, our results support the notion that AbrA1 might
control the phosphorylation state of AbrA2 through both
phosphorylation and dephosphorylation activities. Some putative
cross-talk can also be proposed in view of the intermediate
phenotypes observed in the individual mutants DabrA1 and
DabrA2, and hence non-cognate HKs and RRs might act when
the corresponding partners are absent, although with less
efficiency.
Finally, we show the potential of using the DabrA1/A2 strain to
express secondary metabolites heterologously, offering a new tool
for the biotechnological industry. This strain is able to over-
produce the antitumoral oviedomycin of S. antibioticus [11,12,13]
in an active configuration.
Materials and Methods
Strains, media and culture conditions
Escherichia coli strains BL21(DE3) [14], BW25113/pIJ790
(containing the lRed system) [15], and non-methylating
ET12567/pUZ8002 (containing the tra genes) [16] were grown
in Luria–Bertani (LB) liquid broth or on LB agar. The S. coelicolor
M145 and mutant strains were grown on NA, R2YE, MSA, PGA,
YEPD and NMMP [17]. Several modifications of the NMMP
composition were used (complete medium: 5 g/L glucose, 2 g/L
(NH4)SO4, 0.6 g/L MgSO4, 5 g/L casamino acids, 15 mL/L
0.1 M NaH2PO/Na2HPO buffer, pH 6,8, 1 mL/L trace element
solution (1 g/L ZnSO4.7H2O, 1 g/L FeSO4.7H2O, 1 g/L
MnCl2.4H2O, 1 g/L CaCl2), 20 g/L agar) [18]. Liquid cultures
were performed in 100-mL three-baffled flasks with 15 mL of
medium each. When necessary, the medium was supplemented
with antibiotics (100 mg mL21 of ampicillin, 50 mg mL21 of
apramycin, 50 mg mL21 of kanamycin, 10 mg mL21 of thios-
trepton, 20 mg mL21 of hygromycin, 20 mg mL21 of neomycin,
25 mg mL21 of chloramphenicol, and 25 mg mL21 of nalidixic
acid).
Mutant constructions (TCS knockouts)
The PCR-targeting system established by Gust et al. [19] was
used to replace the corresponding gene or genes by an apramycin
(aac(3)IV gene) resistance cassette, later eliminating the resistance
cassette using Flp recombinase. Mutagenic cassettes were ampli-
fied using the specific primers for each gene (Table S1) and the
pIJ773 plasmid as template. The SRG-059/SRG-045 or SRG-
046/SRG-058 primer pairs were used for the mutagenic cassettes
to replace SCO1744 or SCO1745 respectively. To delete
SCOs1742/43, the oligonucleotides used were AY-043/AY-044
in a first PCR, and AY-045/AY-046 in a second PCR to extend
the flanked regions of the ORFs to be deleted. To construct the
mutagenic cassette for SCOs1742-45, the same forward primer
(AY-043) as that employed for the disruption of SCO1742/43 was
used, and as the reverse primer AY-006P was used both for the
first and for the second PCR. The resistance gene replaced the
corresponding ORFs of the cosmid SCI11 with the corresponding
mutagenesis cassettes in E.coli BW25223/pIJ90, and the mutant
cosmids (DSCD11-2, DSCD11-3, DSCD11-4, and DSCD11-5)
were transferred into S. coelicolor by intergeneric conjugation.
The different Streptomyces null mutants were isolated and
confirmed by PCR and Southern assays.
Plasmid constructions
The plasmids and cosmids used are listed in Table S2. The
response regulator gene abrA2 was amplified in a PCR reaction
using primers AY-047 (including a NdeI site) and AY-048
(including a XhoI site) and cloned into NdeI/XhoI sites from
the pXHis1 plasmid [20], generating an intermediate plasmid
designated pXabrA2His. The BglII fragment containing the
abrA2 gene (Hisx6-tagged) under the xysAp promoter [21] was
cloned into the same site from the Streptomyces pIJ702 plasmid
[22], yielding pTXAbrA2.
To obtain plasmids pTXabrA2-DA and pTXabrA2-DE, D55A
or D55E point mutations were introduced using pairs of
oligonucleotides specific for each mutation in a first step of an
overlapping PCR: AY-047/AY-104 (59 gene fragment DA) and
AY-103/AY-048 (39 gene fragment DA) or AY-047/SRG051 (59
gene fragment DE) and AY-048/SRG-050 (39 gene fragment DE).
Then, using these two overlapping fragments for D55A or D55E
as a template, a second PCR was carried out with AY-047/AY-
048 and the final mutated genes were introduced by NdeI/XhoI
digestion, replacing the non-modified version carried in pTXa-
brA2. In pTXabrA2-DADE, the mutant gene (D10A/D55E) was
amplified using SRG-060/AY-048 oligonucleotides and the
pTXabrA2-DE plasmid as template. This double mutant gene
fragment was substituted as above in pTXabrA2.
For complementation studies, the integrative plasmids pHabrA1
and pHabrA2 were obtained by PCR amplification of abrA1 using
AY-035/SAM-001 oligonucleotides or abrA2 (AY-047/AY-036)
and replacing the abrA1/A2 genes either by abrA1 or by abrA2,
respectively, in the pHabrA plasmid [10] with NdeI/XhoI
digestion.
The new plasmids were introduced into the corresponding
Streptomyces strains by protoplast transformation, as previously
described [17].
The NdeI/XhoI fragment from pXabrA2His was introduced
into pET22b to yield pETabrA2 for protein production and
purification in E. coli. To purify the truncated AbrA2N protein
(141 aas) lacking the C-terminal fraction, the DNA encoding the
N-terminal fraction was amplified using oligonucleotides AY-047
and AY-102 and cloned into the NdeI/XhoI sites of pET22b
(pETabrA2N).
To obtain the pNA4 plasmid, the abrA operon promotor was
amplified by PCR with AY-033 and AY-034, and cloned into the
EcoRI/NdeI sites of pNX4, replacing the xylanase promotor.
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Nucleic acid manipulations
Plasmid isolation, restriction enzyme digestion, ligation, and
transformation of E. coli and S. coelicolor were carried out using
the methods of Sambrook et al. [23] and Kieser et al. [17],
respectively. Total genomic DNA from S. coelicolor (gDNA) was
isolated from 24–36 h cultures in TSB medium following the
procedure described in Hopwood et al. [18], but scaled to 1–2
grams of mycelium.
For RNA extraction from the different strains, 160 mL of
NMMP medium were inoculated in 500-mL baffled flasks with
46106 spores/mL and incubated at 30uC for 72 hours. Prior to
RNA isolation, 20 mL of culture was harvested and suspended in
RNA-protect Bacteria Reagent (Qiagen). Following mycelium lysis
with lysozyme (15 mg/mL in TE at room temperature), three
volumes of RLT buffer from the RNeasy mini plus kit (Qiagen)
were added and mycelia were disrupted using Fast-prep (2 pulses
of 10 seconds at maximum intensity, ice for 5 min between cycles).
The lysate was clarified by centrifugation and the RNeasy mini
Plus (Qiagen) kit was used to purify the RNA, following the
manufacturer’s specifications. The quality and concentration of
RNA were assayed using spectrophotometric assays (Nanodrop
ND1000).
RT-PCR was performed using 0.25 mg of RNA and iScript
Reverse Transcription Supermix to obtain cDNA, following the
manufacturer’s specifications. The specific oligonucleotides AY-
061 and AY-062 were used to analyze SCO1742 expression in the
different mutant strains for 35 cycles.
Phosphorylation by low-molecular weight phosphor-
donors
Phosphorylation reactions were carried out with 2.5 mg of
AbrA2, AbrA2N, or DrrBN protein, used as a control in the
experiments [24]. The phosphorylation buffer was 50 mM Tris-
HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl2 and the low-weight
phosphor-donors used were 20 mM acetylphosphate (Sigma),
100 mM carbamoylphosphate (Sigma) and 150 mM phosphor-
amidate (obtained by chemical synthesis as in Sheridan et al. [25]).
The reactions were incubated at 37uC for 30 minutes, after which
an SDS-PAGE loading buffer without DTT was added to stop the
reaction and was loaded directly (without boiling) into an SDS-
PAGE gel. Electrophoresis was performed at 4uC. The phosphor-
ylated proteins were visualized with Phos-tag 300/460 Phospho-
protein Gel Stain (Perkin Elmer).
Antibiotic determinations
To study the signal that triggers ACT production in the parent
and mutant strains, the cells were grown at 30uC for four days as a
lawn, inoculating 7,56106 spores/plate. The experiments were
repeated twice and five different plates were used for each medium
condition.
In the rest of the experiments, all the endogenous antibiotic
production was observed on plates of solid medium inoculated
with 105 spores, either streaked out or added in a five-mL drop.
The experiments were replicated at least twice on four different
plates in each case. RED production was detected as the red
colour of the colonies on PGA medium after 2 days. For ACT
production, the strains were grown on NMMP at 30uC for at least
3 days to observe a blue halo around the colonies. For CDA
production, the strains were grown on NA medium at 30uC for 2
days. Following this, the plates were overlaid with 5 mL of soft
agar plus 60 mM Ca(NO3)2 inoculated with Bacillus subtilis as the
test microorganism (0.2 mL, 0.25 OD) and incubated at 30uC for
20 hours. A replica plate without calcium was used as a negative
control.
Western blot assays
Total protein extracts were obtained from 5-mL samples (in
triplicate) of the cultures. The proteins were resolved in SDS-
PAGE (15% polyacrylamide in a MiniProtean II system, BioRad).
After transfer to Immobilon-P (Millipore), the proteins were
reacted with a pre-purified polyclonal 1:50000 dilution of anti-
XysA. XysA was detected by chemiluminescence with ECL
western blotting detection reagents following the manufacturer’s
instructions (GE Healthcare), using horseradish peroxidase-cou-
pled anti-rabbit secondary antibody.
Oviedomycin production
The parental strain (M145) and DabrA1/A2 were transformed
with the cosmid CosAB4 containing the oviedomycin cluster and
with empty cosmid pKC505 as a control (Table S2). Oviedomycin
has a yellow colour that turns to orange-brown with time and is
secreted to the culture medium. Oviedomycin production was
analyzed on solid and in liquid NMMP media. On solid medium,
5-mL droplets containing 2.56103 spores of the corresponding
strains were inoculated and the production of colored compounds
was observed after growth at 30uC. In liquid medium, 10 mL of
medium were inoculated with 46105 sp/mL of each strain and
incubated at 30uC at 200 rpm for 5 days.
To perform bioassays against Micrococcus luteus, previous
acetone extraction of solid cultures of the producer strains was
carried out, the evaporated extract was resuspended in methanol,
and 15 mL of this suspension was dropped onto a Whatman disc
placed on a M. luteus lawn inoculated on YEPD. UPLC analysis
for oviedomycin was performed as described in Mendez et al. [13].
Results
Which signal activates the AbrA system?
The AbrA1/A2 TCS is a pleiotropic negative regulatory system.
The DabrA1/A2 strain shows a significantly increased CDA, RED,
and ACT production, and an accelerated morphogenetic program
can also be observed in this strain. The increase in ACT
production is mainly observed in NMMP medium and is
nutrient-dependent [10]. Accordingly, some nutritional compound
might be triggering HK auto-phosphorylation and the subsequent
phosphate transfer to its cognate RR, repressing the antibiotic and
differentiation pathways. When the nutrient becomes limiting, the
pathway may be blocked and the de-phosphorylated RR may be
unable to exert its repressing activity.
Since NMMP medium has a defined composition, the parent
and mutant strains were grown as a lawn (see Materials and
Methods) in complete and modified NMMP media lacking one of
its components independently (phosphate buffer, glucose,
(NH4)2SO4, MgSO4, casamino acids, or one or all of the four
trace elements, respectively). The growth of both strains was
monitored under all the different conditions, no differences being
observed. The hypothesis was that if the nutrient signal were
absent from the medium, the repressing effect exerted by AbrA2
would be prevented in the parental strain.
Both strains were able to produce ACT at the same time and
level when the medium lacked MgSO4. By contrast, the absence of
casamino acids or the trace element solution prevented ACT
production in both strains (Figure 1). A more detailed study
involving the removal of each of the four trace elements separately
demonstrated that this phenotype (non-ACT) was due to the
absence of ZnSO4. Additionally, the elimination of only FeSO4
Streptomyces coelicolor DabrA1/A2 Regulation and Antibiotic Production
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from the medium induced ACT production (de-repression) in the
parent strain, similar to the absence of MgSO4 (Figure 1).
Thus, both casamino acids and ZnSO4 seemed to be essential
for ACT production even in the DabrA1/A2 strain. Zinc is a co-
factor of some ACT biosynthetic enzymes such as cyclase/
dehydratase SCO5090 [26] and some components of casamino
acids are antibiotic precursors (ie. leucine, isoleucine, and valine)
[27], and hence their absence could account for the absence of
ACT production in both strains. However, both MgSO4 and
FeSO4 needed to be present for the repression of ACT production
to be maintained in the wild type, their effects not being additive
(Figure 1: w/o MgSO4/FeSO4). Moreover, the phenotype of
ZnSO4 absence prevailed over the one shown by the absence of
FeSO4 or/and MgSO4, as expected (Figure 1).
Overall, these results offered us relevant information that
narrowed down the activating signal(s) of AbrA system to two
elements Mg and/or Fe. Whether this was a direct activation
(signal sensed by the kinase) or indirect activation remains
unknown.
AbrA operon expression is auto-regulated and responds
to Fe
The promoter functionality of the operon containing the AbrA
TCS, abrAp, upstream of the SCOs1742/43 genes, has been
demonstrated previously in the complementation studies of
DabrA1/A2 [10]. As mentioned above, the expression of many
TCS operons is auto-regulated by the induction/repression of the
promoter through the binding of the phosphorylated RRs to their
own promoters [9,28].
To test the hypothesis that abrAp may be auto-regulated by
AbrA2-P, the multicopy plasmid (pNA4) was obtained. This
plasmid contains as a reporter the xysA xylanase gene from S.
halstedii JM8 under the control of abrAp. A plasmid carrying this
xysA gene under its own promoter was used as a control of the
experiment (pNX4) (Figure 2A). Xylanase production was studied
in the parent strain and the null abrA1/A2 strain, observing that
under abrAp (pNA4) it only occurred in the wild-type strain at
seven days culture (Figure 2B, left panel) although small produc-
tion could be observed at the null abrA1/A2 strain at longer
incubation times. However, no significant differences in produc-
tion were detected between strains when the control plasmid
pNX4 was used at any time (Figure 2B, right panel). Accordingly,
the activation of the operon expression is dependent on the
presence of the abrA1 and abrA2 genes (Figure 2B left). Thus, the
AbrA system positively regulates its operon promoter under these
culture conditions directly through the phosphorylation of AbrA2
or indirectly through other as yet undetermined RRs.
The plasmids pNA4 and the control pNX4 were also used to
study the putative signaling effect of Mg or Fe. The parent strain
M145, harboring pNA4 or pNX4, respectively, was grown in
NMMP complete medium and in derivative media with only
10 mM FeSO4 (low-Fe) or 10 mM MgSO4 (low-Mg). In liquid
cultures, total absence of these compounds did not permit growth
at all of the strains even without the plasmids and consequently
there was no antibiotic production (Figure S1). As mentioned
above, there was normal growth observed on solid medium in
these conditions (w/o Fe or w/o Mg), meaning that the trace
elements present in the agar must be sufficient to allow normal
growth.
As shown in Figure 2C the production of xylanase with abrAp
(pNA4) in low-Fe conditions was considerably reduced with
respect to that obtained with complete NMMP medium or in
medium with low Mg. The observed growth of both strains was
similar under all the different conditions assayed and when the
xysp promoter supported production (pNX4), a similar production
was obtained in all media (Figure 2C, right panel). Thus, iron
seems to act as a signal to activate the expression of the reporter
under abrAp. A low-level production of xylanase was observed
with plasmid pNA4, probably because the compound was not
completely absent. Our hypothesis is that under this condition
(low-Fe) the histidine kinase AbrA1 is mainly unphosphorylated
and therefore the RR AbrA2 is in its inactive unphosphorylated
form and is unable to bind to abrAp and trigger the same level of
expression of the reporter gene as in the NMMP complete
medium. By contrast, the absence of Mg did not correlate with a
diminished production of the reporter. Since Mg is necessary for
the proper functioning of the TCS, we suggest that the small
amount of this element added to the medium (10 mM) might be
sufficient for TCS functionality. In light of these results, we
propose that Fe could be the activating signal of the TCS AbrA1/
A2 in NMMP medium.
Figure 1. AbrA1 HK signal response in NMMP. ACT production
(blue colour) of the parent strain (M145) and the mutant DabrA1/A2
(DabrA) in NMMP complete medium and different modified versions
lacking (w/o) one or several compounds of the original recipe. All plates
were inoculated as a lawn with 7.56106 spores of the corresponding
strains and the images correspond to backward sections of the plates
after four days at 30uC.
doi:10.1371/journal.pone.0109844.g001
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The toxicity of AbrA2 overexpression is dependent on its
phosphorylation state
The effect of the expression of multiple copies of abrA2 in S.
coelicolor M145 and in the DabrA1/A2 strains was studied using
the plasmid pTXabrA2, in which the promoter xysAp controls
abrA2 expression. In both strains the transformation efficiency of
pTXabrA2 was similar to that of the empty vector used as a
control, pIJ702. Nevertheless, the colonies obtained in the
DabrA1/A2 strain exhibited a slow and aberrant morphological
development while in the parent strain the transformed colonies
had a healthy phenotype (Figure 3A). Moreover, the aberrant
DabrA1/A2 (pTXabrA2) colonies grew poorly when they were re-
inoculated onto plates of fresh medium or in liquid medium.
To study whether the selective toxicity in the DabrA1/A2
(pTXabrA2) strain was due to the phosphorylated form of AbrA2
despite the absence of its AbrA1 HK, an AbrA2 phosphoablative
mutant derivative protein was constructed. The putative Asp
residue involved in phosphorylation, Asp55, was replaced by an
Ala. Overexpression of this variant, AbrA2-DA, did not elicit
toxicity either in the wild-type or in the double mutant, showing
the importance of the phosphorylation state of AbrA2 as regards
toxicity (Figure 3A). Once it had been confirmed that this toxic
effect was caused by a hyperactivation of the RR (an excess of
phosphorylated RR), we decided to use this phenotype as readout
to follow the activation of AbrA2 in different contexts. Taken
together, the results were consistent with the notion that AbrA2
phosphorylation still occurred when its cognate HK AbrA1 was
not present. Remarkably, the fact that such overexpression was not
toxic in the parent strain M145(pTXAbrA2), in which the kinase
AbrA1 was present, suggested that this HK might also be
controlling the phosphorylation state of AbrA2 by intrinsic
phosphatase activity, as described in other HKs [9].
To test this hypothesis, an abrA2 phosphomimetic mutant was
generated with the expectation that its expression would be toxic
even when overexpressed in the parent strain. To do so, another
Asp (Asp-10) of the acidic pocket was replaced by Ala, and the
Asp-55 was replaced by Glu (AbrA2-DADE). As shown in
Figure 3A, the overexpression of AbrA2-DADE was toxic in both
strains (parent strain and double mutant). A mild toxicity
phenotype was observed in the wild-type strain, possibly due to
the presence of an unmodified copy of abrA2 in the genome. This
result supported the idea that the AbrA1 HK might be responsible
for the phosphorylation (by phosphotransfer) and dephosphoryla-
tion (by phosphatase activity) of AbrA2, maintaining a balance
between non-phosphorylated and phosphorylated RR at each
moment.
Regarding antibiotic production, the overexpression of AbrA2
in the parent strain, which was not toxic, led to the opposite
phenotypes to those observed in the absence of these genes in
DabrA1/A2. Strain M145 (pTXAbrA2) produced lesser antibiotic
(ACT, RED and CDA) than the strain carrying the empty vector
pIJ702, in contrast to the enhanced antibiotic production of the
DabrA1/A2 (pIJ702) mutant (Figure 3B). The wild-type strain
transformed with the phosphoablative mutant showed an inter-
mediate phenotype between those obtained with the empty and
pTXAbrA2 plasmids due to a remaining unmodified copy of the
abrA2 in the genome.
The individual S. coelicolor DabrA1 and S. coelicolor DabrA2
strains were generated using the PCR-targeting approach
described by Gust et al. [19] (see Materials and Methods).
Phenotypic analysis of the growth and antibiotic production of the
parent strain (M145 strain), DabrA1, DabrA2 and the double
mutant DabrA1/A2, previously described [10], revealed that the
phenotypes (antibiotic production and morphological differentia-
tion) of individual deletion of the AbrA TCS genes were
intermediate between the parent and double mutant strain in
NMMP medium (Figure S2A). These phenotypes were comple-
mented by the pHabrA1 and pHabrA2 plasmids. Transformation
of these strains, DabrA1 and DabrA2, with pTXabrA2 and with
the control pIJ702 demonstrated the toxicity of the overexpression
of AbrA2 in the DabrA1 strain but not in the DabrA2 strain, which
has a functional AbrA1 kinase (Figure S2B). This again points to
other kinases or regulators cross-talking.
Small phospho-donors are not able to phosphorylate
AbrA2 in vitro
As seen in the overexpression experiments, the phosphorylation
of AbrA2 was necessary for it to exert its toxicity and took place
even in the absence of the cognate kinase. A possible explanation
for this could be phosphate transfer from small intracellular
phospho-donors, such as acetyl phosphate, to the RR, as reported
in other systems [8].
The AbrA2 protein with a His(6) tag was expressed and purified
in E. coli and used as a substrate in in vitro phosphorylation assays
by several potential phospho-donors, using a non-denaturing
PAGE procedure. Acetyl phosphate, carbamoylphosphate and
phosphoramidate were used as phospho-donors (see Materials and
Methods) and the protein DrrBN from Thermotoga maritima was
used as a positive control [24]. The phosphorylated proteins were
Figure 2. Auto-regulation of AbrA2 and dependence on Fe. A)
Scheme of plasmids for xylanase gene expression (xysA) used as
reporter. Plasmid pNA4: xysA under the control of abrA promoter
(abrAp) was used, and plasmid pNX4: xysA under the control of its own
promoter xysAp was used as a control. B) Top left panel: xysA expression
triggered by pNA4 (abrAp) in the parent strain (M145) and the DabrA1/
A2 mutant (DabrA), respectively, is shown. Top right panel, control
expression by xysAp (pNX4) in both strains is shown. C) Western blot
showing xysA expression under abrAp (plasmid pNA4), or xysAp,
(plasmid pNX4) in the parent strain M145 in different medium
conditions: complete NMMP, low-Fe or low-Mg media. The xylanase
signal corresponds to western blot assays using anti-xysA against
supernatants of 7-day cultures in NMMP medium (100 mL of pNA4 and
2 mL of pNX4). In the bottom panels of B and C the amount of protein
loaded in each lane is shown with a Coomassie blue stain. Two
independent cultures of each construction are shown.
doi:10.1371/journal.pone.0109844.g002
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visualized using a specific phosphorylation stain (Phos-tag). The
three compounds tested were able to phosphorylate the control
protein DrrBN while no phosphorylation band was observed when
AbrA2 was used (Figure 4A and B). It is possible that the receptor
domain might not be accessible, having a closed conformation
with the effector domain through a domain-domain interaction, as
occurs in other regulators [24,29]. To study this possibility, a
truncated AbrA2 form was generated. The amino terminal
domain AbrA2N (corresponding to the first 141 amino acids)
was expressed and purified, but the results using this receiver
domain as a substrate were also negative (Figure 4C).
Therefore, none of the phospho-donors assayed was responsi-
ble, at least in vitro, for AbrA2 phosphorylation. These results
suggested that AbrA2 phosphorylation in the absence of the
AbrA1 kinase was likely a consequence of other kinases that
phosphorylate AbrA2 non-specifically by cross-talking.
Role of the ABC transport system of the SCO1742/45
operon in antibiotic production
The ABC transporter system encoded directly upstream of the
two-component system on the S. coelicolor chromosome exhibits
sequence similarity to antibiotic and multidrug resistance (MDR)
export transporters. It is encoded by two genes, (SCO1742/43),
one coding for a nucleotide-binding domain (NBD) and the other
a transmembrane domain (TMD). The NBD of the first gene
displays similarities to MDR transporters and to the NBD BcrA of
the Bacillus licheniformis ABC transporter BcrABC, which is
involved in the transport of bacitracin [30]. In order to investigate
its role in antibiotic production and possible interactions with the
two-component system of the operon, two mutants were
constructed using the REDIRECT technology (see Materials
and Methods). In one of them, only the two ABC transporter
genes were deleted (S. coelicolor D1742/43). In the other, all four
genes of the operon were deleted (S. coelicolor D1742-45).
Deletion of the SCO1742 and SCO1743 genes (D1742/43) did
not elicit the early sporulation observed in the DabrA1/A2 strain,
and deletion of the whole operon (D1742-45) resulted in a
Figure 3. Overexpression of abrA2. A) Colony morphology of S. coelicolor M145 and S. coelicolor DabrA1/A2 strains transformed with different
multicopy plasmids: pIJ702 (control), pTXabrA2 (expressing the AbrA2 RR under the control of xysAp), and its derivatives pTXabrA2-DA (D55A) and
pTXabrA2-DADE (D10A, D55E). The photographs correspond to four-day cultures on R2(YE) medium. Bar: 1 mm. B) Phenotypes of AbrA2
overexpression in S. coelicolor M145 compared to the mutant DabrA1/A2 phenotype. The phosphoablative version (pTXabrA2-DA) was included in
the study. Upper part: production of ACT in NMMP medium plates (72 h); middle part: CDA bioassay against B. subtilis at 48 h; lower part, RED
production at 48 h.
doi:10.1371/journal.pone.0109844.g003
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suppression of the DabrA1/A2 phenotype (Figure 5). This
suppression was also observed in ACT and RED production.
Nevertheless, similar to DabrA1/A2, both new mutants produced
higher amounts of CDA on solid NA medium as compared to the
parent strain, the highest CDA production being observed in the
D1742-45 mutant.
The DabrA1/A2 strain as a heterologous host for
antibiotic production
Since AbrA1/A2 was involved in the negative regulation of
antibiotic production we wondered whether the null strain
DabrA1/A2 might be a good candidate for the heterologous
expression of antibiotic clusters from other organisms. The
oviedomycin biosynthetic gene cluster from S. antibioticus ATCC
11891 [11,12,13] was used to check this possibility. The cosmids
containing the oviedomycin cluster (CosAB4) and the empty one
(pKC505) were introduced in the parental and mutant strains,
M145 and DabrA1/A2, and production of this compound was
checked in solid and liquid NMMP media (see Materials and
Methods).
As observed in Figure 6A, a brown-reddish compound corre-
sponding to oviedomycin was produced in both strains on solid
medium, and the production by the DabrA1/A2 mutant was
higher than in M145. Moreover, bioassays against M. luteus
showed that the product was functional and that the strain with
the greatest growth-inhibiting potential was DabrA1/A2 (CosAB4)
(Figure 6B). Production in liquid medium was also assessed and
the same result was observed (Figure 6C). Interestingly, the
production of oviedomycin occurred earlier in time and even
displaced the ACT production observed in the strains carrying the
empty cosmid in both solid and liquid media (blue colour). UPLC
assays showed that the colour observed in the strains carrying
CosAB4 corresponded to oviedomycin and that the mutant strain
produced double amount of oviedomycin as compared with M145
(Figure S3).
Accordingly, the antitumoral angucyclinone polyketide oviedo-
mycin was produced heterologously in S. coelicolor M145, with a
significantly increased efficiency in the mutant strain lacking the
TCS AbrA1/A2.
Discussion
The negative antibiotic regulator TCS AbrA1/A2 (AbrA), also
involved in morphological differentiation [10], forms part of an
operon with two genes that constitute an ABC transporter system,
one encoding an ATPase and the other a permease with similarity
to the BcrAB-type transporters described for firmicutes [31]. The
operon has positive auto-regulation through the AbrA system. Its
expression activation is dependent on the presence of the abrA1
and abrA2 genes (Figure 2B left). Although the involvement of
transcriptional regulators other than AbrA2 cannot be ruled out,
based on the conventional mode of action of TCSs it seems likely
that the RR would control its own expression. However, a basal
expression of the genes explains the phenotypes observed in this
work with the different mutants obtained. In the D1742/43 strain,
lacking the ABC system, the level of antibiotics and morphological
differentiation were similar to those of the parent strain, because
the TCS that controls these pathways was functioning at its
normal level as shown by q-RT-PCR (data not shown).
Nevertheless, when only the abrA1/A2 genes were absent, an
Figure 4. Phosphorylation assays with small phospho-donors.
Phosphorylation of DrrBN (A), AbrA2 (B) or AbrA2N (C) proteins with
acetylphosphate (AP), carbamoylphosphate (CP) or phosphoramidate
(PA) visualized with the Phos-tag stain in SDS-PAGE (‘‘-’’ means no
phospho-donor added). In the bottom part of each panel the amount of
protein used is shown with a Coomassie blue stain.
doi:10.1371/journal.pone.0109844.g004
Figure 5. Antibiotic production and morphological differenti-
ation of different SCO1742-45 operon mutants. Production of ACT
on NMMP at six days of growth; CDA at two days of growth in NA
medium; RED at two days in PGA, and morphological differentiation at
six days of growth in MSA.
doi:10.1371/journal.pone.0109844.g005
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increased level of ACT and RED production and an accelerated
differentiation were observed, whereas in the strain lacking the
four genes (D1742-45) these phenotypes were suppressed. As
expected, the basal expression of ABC genes in the DabrA1/A2
strain was corroborated by RT-PCR (Figure S4). This suggests
that there is an essential role of ABC genes in the transport of
compounds necessary for the observed antibiotic overexpression,
and that a basal expression is sufficient for this function to be
performed. In fact, on the S. coelicolor chromosome genes with
related function are frequently arranged adjacent to each other
[32]. Thus, a possible explanation might be that the ABC
transporter could be involved in the expulsion of harmful or toxic
by-products coming from the biosynthesis of these antibiotics or
one of the precursors needed. Efflux pumps for an antibiotic itself
however, are more likely to lie directly within the respective
biosynthetic gene cluster, as demonstrated for the ACT cluster
[33,34].
A study carried out on the major facilitator superfamily putative
MDR transporter EbrC in S. lividans demonstrated that its
deletion leads to retardation in morphological differentiation on
specific media, whereas its natural role in drug resistance remains
unclear [35]. These authors therefore proposed that the actual role
of most MDR transporters in streptomycetes would consist of the
export of toxic intermediate catabolic products from the cell,
rather than of the efflux of externally added drugs. However, it is
important to note that in our study the deletion of the ABC
transporter in the mutant D1742/43 did not negatively influence
differentiation on the solid media used. Instead, its deletion in the
mutant D1742-45 somehow prevented an acceleration of
differentiation, as noted for the mutant DabrA1/A2.
On the other hand, we observed that when AbrA2 was
overexpressed in a mutant lacking the kinase gene, the phosphor-
ylation of AbrA2 was responsible for a toxic phenotype since a
phosphoablative mutant did not produce it. Crosstalk from other
kinases might explain the activation of AbrA2 in the absence of
AbrA1; additionally, phosphorylation by low-molecular weight
phospho-donors in vivo could provide an additional mechanism
for this activation. Nevertheless, this phosphorylation was not
observed in vitro when small phospho-donors were used in the
reaction. The phenotypes of the kinase mutants of other different
TCSs have also shown that response regulators such as CheY and
CheB can be phosphorylated in the absence of their cognate
kinases [8]. The intermediate phenotype of the DabrA1 with
respect to the parent and double mutant strains also corroborates
an unspecific, less efficient phosphorylation of AbrA2 by other
kinases in the absence of AbrA1. Cross-talk in the other direction,
meaning that the AbrA1 HK phosphorylates other RRs in the
absence of AbrA2, can also be considered, because the single
mutant lacking the AbrA2 RR, DabrA2, also had an intermediate
phenotype.
Due that the toxic effect was not observed in the parent strain
we propose that the kinase AbrA1 might be controlling the
phosphorylation state of the RR by adjusting the long-term steady-
state levels of activated molecules by de-phosphorylation and
therefore that this control could prevent the toxicity of AbrA2
overexpression in the parent strain. Histidine-kinases frequently
function as phosphatase-activating proteins to facilitate the de-
phosphorylation of response regulators. In some cases, this may be
their principal regulatory role [8]. The AbrA1 phosphatase control
would not occur in the DabrA1/A2 or DabrA1 strains, in which the
phosphorylation must be carried out by other kinases or phospho-
donors and therefore the presence -due to overexpression- of more
activated AbrA2-P molecules could cause toxicity. In conclusion, it
seems that there are alternative phosphorylation mechanisms of
AbrA2 but no alternative de-phosphorylation mechanisms.
A detailed study of the components of the defined medium
NMMP in which TCS null-mutant phenotypes were observed
allowed us to determine that the presence of Fe and Mg was
necessary for the repression of antibiotic production mediated to
be maintained. Besides, the auto-positive activation of the operon
promoter of AbrA system responds directly or indirectly to the
presence of Fe, as also corroborated using the xysA-reporter
plasmid pNA4. In contrast, Mg does not seem to be important for
activation of the expression of AbrA system in the promoter
activity triggered by this system. Since polyketide synthesis does
not require the presence of iron, iron deficiency may represent a
significant regulation factor. In fact, Coisne et al. reported that
ACT was produced early on a defined culture medium under
conditions of iron deficiency and that the excretion of ACT
appeared to be closely related to iron deficiency [36]. Because
there is no iron-binding domain (hemo), detected with Heme-
BIND software [37], in the structure of the AbrA1 HK sensor
domain, an auxiliary protein could play a role in this binding, such
as in the HbpS-SenS-SenR system of S. reticuli [38]. Alternatively,
a more complex network containing other TCSs could be
involved, such as the PhoP/Q- PmrA/B interactions described
in Salmonella [39,40]. More studies are needed to determine how
this metal mediates the AbrA signaling pathway.
Finally, the capacity of the strain lacking the TCS system,
DabrA1/A2, to overproduce oviedomycin, an angucyclinone
Figure 6. Oviedomycin production. Oviedomycin production of
M145 and DabrA1/A2 strains carrying the cosmid CosAB4, containing
the oviedomycin cluster, or an empty control pKC505. A) Solid NMMP
medium at 4 days of growth. B) Antibiotic activity against M. luteus of
acetone-methanol (solvents) extracts from the different strains grown
for 6 days on solid NMMP. C) Supernatant of liquid NMMP cultures at 24
and 120 hours of growth.
doi:10.1371/journal.pone.0109844.g006
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polyketide produced by S.antibioticus ATCC 11891, has been
demonstrated. This antibiotic shows antitumor activity in vitro
and induces apoptosis in cancer cell lines. Use of the genetically
modified strain described here as a heterologous host could
contribute to the production of new antibiotics or to improvements
in the production efficiency of compounds from species that are
not so effective at producing their own secondary metabolites, thus
exploiting the ‘‘hidden biosynthetic’’ potential available in all
Streptomyces genomes [41,42].
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